Mainz Biomed N.V. (MYNZ)
NASDAQ: MYNZ · Real-Time Price · USD
0.6237
-0.0517 (-7.65%)
At close: Feb 18, 2026, 4:00 PM EST
0.6237
0.00 (0.00%)
After-hours: Feb 18, 2026, 4:41 PM EST
Mainz Biomed Market Cap
Mainz Biomed has a market cap or net worth of $6.73 million as of February 18, 2026. Its market cap has decreased by -67.18% in one year.
Market Cap
6.73M
Enterprise Value
8.09M
1-Year Change
-67.18%
Ranking
Category
Stock Price
$0.62
Market Cap Chart
Since the IPO on November 5, 2021, Mainz Biomed's market cap has decreased from $58.55M to $6.73M, a decrease of -88.50%. That is a compound annual growth rate of -39.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 7.29M | -28.15% |
| Dec 31, 2025 | 10.15M | -30.28% |
| Dec 31, 2024 | 14.55M | -38.37% |
| Dec 29, 2023 | 23.62M | -77.05% |
| Dec 30, 2022 | 102.90M | -17.54% |
| Dec 31, 2021 | 124.78M | 113.12% |
| Nov 5, 2021 | 58.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FONAR | 121.54M |
| Biodesix | 101.67M |
| Exagen | 75.01M |
| Precipio | 41.77M |
| Check-Cap | 13.05M |
| Inotiv | 10.04M |
| Advanced Biomed | 6.51M |
| bioAffinity Technologies | 4.81M |